The Medicines and Healthcare Products Regulatory Agency (MHRA) says some packs of lercanidipine, manufactured by Recordati Pharmaceuticals, have been wrongly labelled as containing 10mg tablets when ...

An alert has been issued warning patients to check their medication after a misprint "error" on packaging. The "urgent" ...

The warning from the Medicines and Healthcare products Regulatory Agency (MHRA) comes after the manufacturer informed them of ...

Patients who take the common blood pressure medicine Lercanidipine HCI 20 mg tablets (lercanidipine hydrochloride) from the ...

Lercanidipine is a calcium channel blocker, which works by blocking calcium from entering the heart and blood vessel muscles, ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning after one batch of Lercanidipine, produced by Recordati Pharmaceuticals, was wrongly labelled ...

The Medicines and Healthcare products Regulatory Agency has issued an urgent warning to thousands of patients taking a common high blood pressure drug ...

The warning comes after a Recordati Pharmaceuticals reported an error in the labelling on some packs of Lercanidipine ...

The Medicines and Healthcare products Regulatory Agency has urged patients who have been prescribed the drug to check ...

More than 7,700 packs are affected by the recall, according to the Medicines and Healthcare products Regulatory Agency.

The blister card market is rapidly evolving, with the industry projected to see substantial growth in the coming decade. By ...